Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Moshkevich Solomon. Officer active across 1 company, notably Natera, Inc.. Cumulatively, 65 filings have been logged. Split: 0 buy · 49 sells. Total volume traded: €17.8m. History available since 28 March 2024. The latest transaction was filed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Moshkevich Solomon Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 65 total
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 410 shares @ US$267.9893 0.0003% mcap 0.5% of flow Common Stock SEC:0002010019-26-000024:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 300 shares @ US$259.98 0.0002% mcap 0.4% of flow Common Stock SEC:0002010019-26-000024:1
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 200 shares @ US$261.4875 0.0001% mcap 0.3% of flow Common Stock SEC:0002010019-26-000024:2
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 947 shares @ US$263.9415 0.0006% mcap 1.2% of flow Common Stock SEC:0002010019-26-000024:3
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 192 shares @ US$265.275 0.0001% mcap 0.2% of flow Common Stock SEC:0002010019-26-000024:4
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 1,233 shares @ US$267.7869 0.0009% mcap 1.6% of flow Common Stock SEC:0002010019-26-000024:5
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 3 Aug 2026 · Natera, Inc. 128 shares @ US$268.6964 0.0001% mcap 0.2% of flow Common Stock SEC:0002010019-26-000024:6
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 27 Jul 2026 · Natera, Inc. 1,010 shares @ US$260.4908 0.0007% mcap 1.4% of flow Common Stock SEC:0002010019-26-000021:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 28 Jul 2026 · Natera, Inc. 1,204 shares @ US$254.0705 0.0008% mcap 1.6% of flow Common Stock SEC:0002010019-26-000021:1
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 1 Jul 2026 · Natera, Inc. 100 shares @ US$267.185 0.0001% mcap 0.3% of flow Common Stock SEC:0002010019-26-000016:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 1 Jul 2026 · Natera, Inc. 2,600 shares @ US$272.99 0.0018% mcap 7.1% of flow Common Stock SEC:0002010019-26-000016:1
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 1 Jul 2026 · Natera, Inc. 300 shares @ US$274.06 0.0002% mcap 0.8% of flow Common Stock SEC:0002010019-26-000016:2
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 27 Apr 2026 · Natera, Inc. 997 shares @ US$203.75 0.0005% mcap 1.9% of flow Common Stock SEC:0002010019-26-000012:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 27 Apr 2026 · Natera, Inc. 1,185 shares @ US$204.39 0.0006% mcap 2.3% of flow Common Stock SEC:0002010019-26-000012:1
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 1 Apr 2026 · Natera, Inc. 1,048 shares @ US$201.3206 1.9% of flow Common Stock SEC:0002010019-26-000011:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 1 Apr 2026 · Natera, Inc. 1,000 shares @ US$202.3638 1.8% of flow Common Stock SEC:0002010019-26-000011:1
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 1 Apr 2026 · Natera, Inc. 952 shares @ US$203.3106 1.7% of flow Common Stock SEC:0002010019-26-000011:2
◆ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 9 Mar 2026 · Natera, Inc. 1,774 shares Common Stock SEC:0002010019-26-000008:0
◆ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 27 Feb 2026 · Natera, Inc. 10,051 shares Common Stock SEC:0002010019-26-000007:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 2 Feb 2026 · Natera, Inc. 80 shares @ US$228.50 0.1% of flow Common Stock SEC:0002010019-26-000006:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 27 Jan 2026 · Natera, Inc. 1,013 shares @ US$240.5313 1.2% of flow Common Stock SEC:0002010019-26-000005:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 20 Jan 2026 · Natera, Inc. 23,205 shares @ US$234.7384 28.3% of flow Common Stock SEC:0002010019-26-000004:0
◆ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 14 Jan 2026 · Natera, Inc. 44,698 shares 0Common Stock SEC:0002010019-26-000003:0
▼ PRESIDENT, CLINICALDIAGNOSTICS · Executives · 2 Jan 2026 · Natera, Inc. 1,292 shares @ US$228.3294 1.5% of flow Common Stock SEC:0002010019-26-000002:0
● PRESIDENT, CLINICALDIAGNOSTICS · Executives · 12 Dec 2025 · Natera, Inc. 180 shares 0Common Stock SEC:0002010019-25-000016:0
25 of 65 declarations
Load more (40 remaining) About Moshkevich Solomon Moshkevich Solomon is PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. Across 56 filings in total, the 56 sampled filings cover the period from 2024-01-30 to 2026-07-06 and consist only of sales, with a total amount of EUR 16524250.